Advancing Vaccines
For Better Lives

Welcome to Valneva

We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease and Zika.

Learn More

Check out our 2023 Annual Business Report

Learn More

Follow Us

Preventing the spread of infectious diseases is crucial to maintaining public health. This #WorldImmunizationWeek, let's celebrate the role vaccines play in helping to increase health in communities around the world.
#HumanlyPossible

#WorldImmunizationWeek is all about helping children, adults and their communities live happier, healthier lives – because vaccine-preventable diseases shouldn’t be a barrier to enjoying life.
#HumanlyPossible

At Valneva, our vision is to contribute to a world in which no one dies or suffers from a vaccine preventable disease.
Join us in recognizing the importance of vaccination during #WorldImmunizationWeek.
#HumanlyPossible

Load More